Skip to content
Recall Observatory FDA recall evidence

Drug product

Neostigmine Methylsulfate Injection, USP, 3 mg/3 mL (1 mg/mL) syringe, packaged in 5 x 3 mL Pre-Filled Syringes per carton, 6 x 5 Syringe Carton per case, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-932-03

D-1270-2022

June 30, 2022

Class II

Product summary

Firm
Nephron Sterile Compounding Center LLC
Event
Event 90512
Status
Terminated
Classification
Class II
Quantity
59,520 syringes
Official record key
drug-enforcement:D-1270-2022

Official wording

Reason: Lack of Assurance of Sterility

Code information: Lots:NE2002A, Exp. 7/14/2022; NE2003A, Exp. 7/24/2022; NE2006A, Exp. 8/1/2022; NE2007A, Exp. 8/9/2022; NE2008A, Exp. 8/18/2022; NE2009A, Exp. 8/27/2022; NE2012D, Exp. 10/3/2022

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility